LIMNW vs OKE
Liminatus Pharma, Inc. Warrants (LIMNW) versus ONEOK Inc (OKE) — a side-by-side from cached financials, not a winner call.
Liminatus Pharma, Inc. Warrants (LIMNW) is a biotechnology company listed on US.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
LIMNW does not have a complete income-statement cache yet.
Latest reported OKE revenue for 2026-06-30 was $21.67B. Net income was $1.74B. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
LIMNW currently screens at market cap $0. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Not investment advice. Open the LIMNW and OKE stock pages for the full models.
Not investment advice.